Class I histiocytosis: response to combination of etoposide and prednisolone.
Datta
V
V
Departments of Pediatrics and Pathology, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221 005, India.
Mishra
O P
OP
Das
B K
BK
Kumar
M
M
Bhargava
V
V
Singla
P N
PN
D002675:Child, Preschool; D004359:Drug Therapy, Combination; D005047:Etoposide / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use*; D006646:Histiocytosis, Langerhans-Cell / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007275:Injections, Intravenous; D008297:Male; D019384:Nucleic Acid Synthesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D012074:Remission Induction
D005938:Glucocorticoids; D019384:Nucleic Acid Synthesis Inhibitors; D005047:Etoposide; D011239:Prednisolone